Independent Medical Education Grants

Due to the recent news that Oncopeptides has voluntarily withdrawn PEPAXTO® in the U.S. and will close the U.S. commercial business unit, we will not consider any grants for 2022, unfortunately. We sincerely thank you for your support and interest in Oncopeptides and the treatment of patients with relapsed or refractory multiple myeloma.

Oncopeptides offers support to meritorious grant proposals from accredited providers towards Continuing Medical Education (CME) of all Health Care Professionals (HCPs) in USA. Currently, we are accepting grants for education activities in the unmet need of Relapsed and Refractory Multiple Myeloma (RRMM). We request providers to submit their grant proposals through our online grant application and allow at least 8 weeks from the date of submission for our response.

FAQ

Who should I contact with questions regarding grants?

Send your question(s) via email to cme-grants-us@oncopeptides.com

Do you accept grant requests throughout the year?

Due to the recent news that Oncopeptides has voluntarily withdrawn PEPAXTO® in the U.S. and will close the U.S. commercial business unit, we will not consider any grants for 2022, unfortunately. We sincerely thank you for your support and interest in Oncopeptides and the treatment of patients with relapsed or refractory multiple myeloma.

When should I expect a decision from Oncopeptides?

Oncopeptides would like to get at least 8 weeks of time from the date of submission to respond.